Marengo Therapeutics’ Post

This article from Dr. Steven Fang, Founder and Executive Director of Invitrocue Limited, explores the highs & lows of being a bio-entrepreneur & the exciting future of the field. Read the full story for insights & inspiration: https://lnkd.in/gKHCpXse #e27commuity #biotech

👏 EIT Health joins the European #COBIOE project alongside 4 other health networks to help secure Europe's position as a world leader in biomanufacturing! 🇪🇺👨🔬 With the support of the European Commission 5 health clusters across EU join forces to interconnect biomanufacturing ecosystems, thereby supporting the growth and sustainability of this competitive sector in Europe: •⁠ ⁠Council of European BioRegions - CEBR •⁠ ⁠Genopole •⁠ ⁠EIT Health •⁠ ⁠ScanBalt BioRegion •⁠ ⁠Health Cluster Portugal Through this partnerships, COBIOE - Growing Connection for BIO Ecosystems aims at establishing a cross-border value chain linking European players, via 5 key objectives: 🎯 Strengthen European industrial bioproduction capacities 🎯 Reduce the skills shortage and retain skilled workers 🎯 Facilitate access to public and private fundings 🎯 Accelerate research and innovation to discover new treatments 🎯 Promote the field and raise public awareness! #HealthInnovation #Innovation #Biomanufacturing #Europe

“[…] a lot of the innovation that we do pre clinically can be completely wiped away or absolutely augmented. Once you get into the clinic and things can be flipped around[…]”   Global BioAccess Fund's Chief Scientific Officer, Lisa Wisniewski, PhD's comments on how easily assumptions can be flipped around and the different forms of innovation in this sector. Check out the link below to hear the entire conversation between Bruce Roberts, Aldo Maccari, Stephane Piat, and Lisa Wisniewski, PhD in the most recent webinar focusing on current and future investment trends in the Bio/MedTech sector.   #KoboFunds #biotechindustry #medtechinnovation

One of the most exciting parts of my job is getting to showcase the work of those companies that are leading the advancement of innovative medicine, from Poland to the rest of the world. Such is the case of Molecure, a true beacon of the Polish biotechnology sector's potential to become a driver of growth for the national economy. Thank you Marcin Szumowski for taking the time to share your valuable insights with Executive Forecast. #RoadmapToSustainableHealthcare #Poland2024 #IndustryInsights

🎙️ Molecure's CEO, Marcin Szumowski, recently had an interview with Executive Forecast, where he discussed #Molecure's pivotal role in revolutionizing the healthcare sector in Poland. The conversation delves into our pioneering initiatives and the potential impact on healthcare globally 🌍💊   👉 Dive deeper into the interview with George Spirakis and Mónica Vargas Whittle: https://lnkd.in/dP8U5rA7    #HealthcareInnovation #Biotechnology #ExecutiveForecast

🔬 While the science at the heart of Accelerated Biosciences is complex, our approach to business is straightforward. By leveraging our extensive research expertise and in-depth regulatory knowledge, we offer our partners a streamlined path to success. This approach not only saves valuable time but also significantly reduces costs. With us, complexity in science meets simplicity in collaboration. #SimplifyingInnovation #BiotechBusiness

📢 The 2023 BioRegion Report promoted by Biocat, BioRegion of Catalonia is already out, and we're thrilled to be featured as a leading CAR-T company in the region. Here are some key highlights: 🚀 1,400 companies and 91 research entities make up Catalonia’s #lifesciences and #healthcare sector, emerging as a key catalyst for innovation, economic and social advancement. 💰 Despite the global geopolitical, financial and economic context, the investment has declined but remains above €200 M. 🏥 In 2023, 88.5% of all #clinicaltrials in Spain were conducted in Catalonia, which places it 5th in Europe and 8th in the world. We're proud to contribute to this achievement through our #CARxALL trial for T-ALL. 🔬 In terms of patent applications for #advancedtherapies, Catalonia's contribution is notable, with 30 international patents filed during 2013-2022. #OneChain is among those seeking these inventions. We are proud to be part of this vibrant ecosystem that drives us forward! Read the full report here: https://report.biocat.cat/

We are thrilled to have attended the insightful presentation of the BioRegion Catalonia Report 2023 released by Biocat, BioRegion of Catalonia, offering a comprehensive overview of the powerful life sciences sector in Catalonia and Barcelona.     Barcelona and Catalonia tick all the boxes in terms of what is needed to play a prominent role in the Life Sciences industry: outstanding infrastructures, world-renowned hospitals, a vibrant business ecosystem and a city that is at the cutting-edge of science and offers an exceptional quality of life that continues to attract talent to the city.    Some figures that demonstrate the robustness of the Life Sciences ecosystem:   1,400 companies and 91 research institutions  +€ 42 M turnover  +263,900 employees  +€1,025 M of FDI in the sector in 2023  +€220 M in investment raised by startups and scaleups  #3 in number of publications (per M hab) on advanced therapies in Europe  #5 in Europe and #8 worldwide in participation in active clinical trials    Find out more:  https://report.biocat.cat/  

We love investing in the growth of the Phoenix Bioscience Core. You will see some highlights of #850PBC in the video. The future is bright for Phoenix! #phoenixarizona #bioscience #lifescience